Page last updated: 2024-12-07

acetylphenylalanamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID111295
CHEMBL ID2336907
SCHEMBL ID6248471
MeSH IDM0095735

Synonyms (23)

Synonym
acetylphenylalanamide
(2s)-2-acetamido-3-phenylpropanamide
7376-90-1
benzenepropanamide, alpha-(acetylamino)-, (s)-
CHEMBL2336907
ac-phe-nh2
DTXSID10224114
n-alpha-acetyl-l-phenylalanine amide
mfcd00080840
AKOS024259128
SCHEMBL6248471
acetyl-l-phenylalanine amide
acetyl-l-phenylalaninamid
n-acetyl-l-phenylalanine amide
(s)-2-acetamido-3-phenylpropanamide
ac phe-nh2
F11015
AS-46952
ac-phe nh2
ac phe nh2
n-acetylphenylalanyl-amide; (s)-2-acetamido-3-phenylpropanamide
ac-l-phe-nh2
benzenepropanamide,a-(acetylamino)-,(as)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID734191Inhibition of UBR protein in rabbit reticulocyte lysates assessed as inhibition of Tyr-nsP4 substrate degradation at 2 mM2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Development and characterization of monomeric N-end rule inhibitors through in vitro model substrates.
AID734192Inhibition of UBR protein in rabbit reticulocyte lysates assessed as inhibition of Tyr-nsP4 substrate degradation at 2 mM by immunoblotting analysis in presence of bestatin2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Development and characterization of monomeric N-end rule inhibitors through in vitro model substrates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]